Generics

Filter

Current filters:

None

Popular Filters

1001 to 1025 of 1223 results

US House Bill will establish inspection parity, improve US drug supply

06-03-2012

Ranking US Congress Member Henry Waxman, Health Subcommittee Ranking Member Frank Pallone, Representative…

GenericsLegalNorth AmericaPharmaceuticalPoliticsRegulation

New US GAO report highlights critical role of generics in containing health spending

04-03-2012

Prescription drug spending in the USA reached $307 billion in 2010 - an increase of $135 billion since…

GenericsHealthcareNorth AmericaPricing

Prospects for global generic drugs market viewed by F&S

04-03-2012

While the global generic pharmaceuticals market is expected to peak in 2012 as a result of the patent…

GenericsGlobalMarkets & Marketing

EU Commission proposes faster access to medicines for patients

02-03-2012

With the intention of getting new medicines to the market faster, the European Commission yesterday proposed…

EuropeGenericsMarkets & MarketingPharmaceuticalPricingRegulation

Hi-Tech and Mylan update on generics

01-03-2012

US generic drugmaker Hi-Tech Pharmacal (Nasdaq: HITK) says that the US Food and Drug Administration has…

GenericsMarkets & MarketingNeurologicalNorth AmericaRegulation

Frontage and Fanghui Pharma launch $10 million collaboration

28-02-2012

Emerging Chinese pharmaceutical company Luohe Fanghui Pharmaceutical has launched a new globalization…

Asia-PacificFanghui PharmaceuticalsFinancialFrontage LaboratoriesGenericsNorth AmericaRegulation

Future for biosimilars hugely promising, Momenta CEO tells GPhA meeting

26-02-2012

Craig Wheeler, chief executive of Momenta Pharmaceuticals (Nasdaq: MNTA) discussed the promise and prospects…

BiotechnologyGenericsMarkets & MarketingMomenta PharmaceuticalsResearch

Medicines are good value for money in UK, says DoH report

24-02-2012

A UK Department of Health released yesterday endorses the current voluntary agreement between the DoH…

EuropeGenericsHealthcarePharmaceuticalPoliticsPricing

Australia’s GMiA advises pharmacists on maximizing profitability in 2012

24-02-2012

Pharmacists in Australia need to act now to try to increase their dispensaries' profitability in 2012,…

Asia-PacificGenericsMarkets & MarketingPricing

Sanofi considers expanding in Ukraine pharma market

24-02-2012

French drug major Sanofi (Euronext: SAN) is considering a massive expansion into the Ukrainian pharmaceutical…

EuropeGenericsMarkets & MarketingPharmaceuticalSanofi

Ranbaxy posts $586 million loss due to charges

23-02-2012

India’s largest drugmaker Ranbaxy Laboratories (RAB: BO), which is 64% owned by Japan’s Daiichi…

Daiichi SankyoFinancialGenericsRanbaxy Laboratories

Mylan gets tentative FDA approval for generic Epzicom

23-02-2012

US generics major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Laboratories has received tentative…

Anti-viralsEpzicomGenericsGlaxoSmithKlineMylan LaboratoriesNorth AmericaPfizerRegulationViiV Healthcare

Mylan 4th-qtr profits beat expectations, but not sales

21-02-2012

US generic drugs major Mylan (Nasdaq: MYL) yesterday posted financial results for the three months and…

FinancialGenericsMylan Laboratories

Generic drugs key to unlocking savings for Australian economy, says MJA

20-02-2012

A report in the latest issue of the Medical Journal of Australia (MJA), has backed the case for the government…

Asia-PacificGenericsHealthcarePricing

Opportunities for Pharma in narcolepsy

20-02-2012

The narcolepsy therapeutics developmental pipeline is weak, with only six molecules in development, providing…

BioprojectCephalonGenericsMarkets & MarketingNeurologicalNuvigilPharmaceuticalProvigilResearchTeva Pharmaceutical IndustriesUCBXyrem

Pfizer and Hisun flesh-out plans for generics JV in China

19-02-2012

Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceutical (SSE Code: 600267), a leading…

Asia-PacificGenericsMergers & AcquisitionsPfizerZhejiang Hisun Pharma

Actavis to debut generic Aricept in EU markets as patents expire

16-02-2012

Icelandic generics firm Actavis yesterday announced the launch of donepezil, a generic copy of Eisai…

ActavisAriceptdonepezilEisaiEuropeGenericsMarkets & MarketingNeurologicalPfizer

Merck & Co sets up marketing JV in Brazil

16-02-2012

Merck & Co (NYSE: MRK) says it has formed a new joint venture with Supera Farma Laboratorios, a Brazilian…

CristaliaEurofarmaGenericsMarkets & MarketingMerck & CoMergers & AcquisitionsPharmaceuticalSouth AmericaSupera Farma

Teva Pharma strong sales growth helped by acquisitions

16-02-2012

Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) reported fourth-quarter 2011 results…

CephalonFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Impending biologics patent expiries creates huge opportunity for European biosimilars makers

15-02-2012

The biosimilars manufacturing industry is at a nascent stage. However, the impending patent expiries…

BiotechnologyEuropeGenericsMarkets & MarketingPatents

1001 to 1025 of 1223 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top